Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support an extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians want to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the DiffuSphere technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia's DiffuSphere technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, also to be applicable in oncology, infectious disease and other critical disease areas.
Eupraxia's EP-104GI is currently in a Phase 1b/2 trial, the RESOLVE trial, for the treatment of EoE. EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. This is a unique treatment approach for EoE. Eupraxia also recently completed a Phase 2b clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. The trial met its primary endpoint and three of the four secondary endpoints. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Company's website at:
As our Clinical Research Associate (CRA) you will be primarily responsible for the operational management and oversight of Eupraxia clinical study’s monitoring.
Travel requirement: Must be willing to travel domestically and internationally (approximately 20-25%), as needed
Reports to: SVP of Clinical Operations
Salary Range: $115,000 - $145,000 annually depending on education and relevant experience.
...Pharmaceutical Sales Representative (Entry level or experienced) We are currently looking to add excellent sales individuals to our professional Pharmaceutical Sales Rep team. We are a privately held company and offers a great corporate culture that includes award...
...group. About Twin Cities Physicians: Twin Cities Physicians is Minnesotas go-to provider for community-based primary care , serving senior living facilities with compassion and expertise. Were committed to providing flexible, proactive care while empowering...
...bonuses and Peer Recognition Rewards Qualifications : At least 5 years of experience in survey, with at least 1 year at the Crew Chief level Ability to effectively communicate with contractors, inspectors, and team leaders. The ideal candidate will have prior...
...Looking for a part-time job? Work where and when you want and earn some extra money on the side!... ...across Austria and Germany online from home or in your area and organise your working... ...your lessons based on your knowledge and experience Requirements No previous teaching...
...history. We have an immediate opportunity to join the Corporate Environmental Remediation Team as the Manager of Environmental Engineering... ...environmental, chemical, civil, and mechanical) or relevant science field (including environmental science and geology) Proven...